For inhibitory effects, IFNs (mostly IFNγ) have historically been characterized to be integral for anti-tumor immunity by driving antigen presentation (Gettinger et al, 2017) and chemokine secretion (Chheda et al, 2016) that are typically part of the immune-editing process in normal physiological conditions. The gene discussed is IFNG; the disease is neoplasm.